Skip Navigation

Diabetes (type 2) - pioglitazone (replaced by TA63)

Guidance type:  Technology appraisal
Date issued:  March 2001
Guidance currently being reviewed:  See review
Reference:  TA21

Summary

This guidance has been replaced by Diabetes (type 2) - glitazones (review).
Top

Documents

For healthcare professionals

  • None found

For patients, carers and the public

  • None found

Background information

Implementing this guidance

Any further information NICE has produced to help the NHS implement this guideline locally is linked to below:

  • None found
Top

Search NICE guidance


Advanced guidance search

Related guidance

Click the links below to see guidance on similar topics

Order NICE guidance

Order printed copies of our guidance